Related Experiment Videos
TNF alpha-induced activation of eosinophil oxidative metabolism and morphology--comparison with IL-5
1Department of Dermatology, University of Freiburg, Germany.
Abstract:
Human dermal mast cells are capable of releasing cytokines, particularly preformed TNF alpha, upon appropriate stimulation. Mast cell activation in vivo was shown to be associated with an influx and activation of inflammatory cells, initially PMN (polymorphonuclear neutrophilic granulocytes) then eosinophils. In order to learn more about the mechanisms by which TNF alpha is capable of activating eosinophils, in the present study the effect of TNF alpha on morphology and function of highly purified normal eosinophils (> or = 95%) was examined. As estimated by transmission and scanning electron microscopy, TNF alpha-stimulated eosinophils appeared to be strictly adherent and flattened exhibiting a characteristic "hemispheric" shape. TNF alpha induced a dose-dependent, long-lasting production of reactive oxygen species as measured by lucigenin-dependent chemiluminescence (CL), even at a concentration of 0.001 U/ml. The maximal response upon stimulation with TNF alpha, however, was significantly lower than optimal effects induced by IL-5. TNF alpha-induced responses were completely inhibited by cytochalasin B and staurosporin, and partially blocked by pertussis toxin. Separation of eosinophils by discontinuous density gradients revealed the existence of at least two hypodense eosinophil populations with a distinct susceptibility to stimulation with TNF alpha. Based on functional assay systems, in contrast to a significant extracellular, only a small intracellular H2O2 production was detected. Accordingly, H2O2 production, detected by an ultrastructural technique, was observed only on the outer surface of the plasma membrane in the contact zones in between adjacent cells. Extracellular as well as intracellular production of H2O2 was completely inhibited by cytochalasin B. TNF alpha-induced activation of eosinophils is most probably mediated by binding to the 55 kD and the 75 kD TNF-receptor since both receptor molecules could be detected by FACS analysis and immune electron microscopy using receptor-specific antibodies. However, in contrast to its effect on eosinophil oxidative response, TNF alpha did not induce the release of significant concentrations of eosinophil cationic protein or eosinophil peroxidase in supernatants of cytokine-stimulated eosinophils, as detected by functional as well as immunological assay systems. These results clearly indicate that TNF alpha represents a potent eosinophil-activating cytokine which may be of relevance in the allergic inflammatory response.
Insights
Tumor Necrosis Factor alpha (TNF alpha) activates human eosinophils, inducing morphological changes and reactive oxygen species production. This cytokine plays a role in allergic inflammation by influencing eosinophil function.
Area of Science:
- Immunology
- Cell Biology
- Inflammation Research
Background:
- Human mast cells release cytokines, including Tumor Necrosis Factor alpha (TNF alpha), upon stimulation.
- Mast cell activation involves inflammatory cell recruitment, including polymorphonuclear neutrophilic granulocytes (PMN) and eosinophils.
- The precise mechanisms by which TNF alpha influences eosinophil activation remain incompletely understood.
Purpose of the Study:
- To investigate the effects of TNF alpha on the morphology and function of highly purified human eosinophils.
- To elucidate the signaling pathways and receptor interactions involved in TNF alpha-mediated eosinophil activation.
- To assess the role of TNF alpha in the context of allergic inflammatory responses.
Main Methods:
- Transmission and scanning electron microscopy to analyze eosinophil morphology.
- Lucigenin-dependent chemiluminescence to measure reactive oxygen species (ROS) production.
- Functional assays with inhibitors (cytochalasin B, staurosporin, pertussis toxin) and density gradient separation.
- Flow cytometry (FACS) and immune electron microscopy to detect TNF receptors.
- ELISA and functional assays to measure eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO) release.
Main Results:
- TNF alpha induced adherence, flattening, and a "hemispheric" shape in eosinophils.
- A dose-dependent, long-lasting production of ROS was observed, though less potent than IL-5.
- TNF alpha-induced responses were modulated by cytochalasin B, staurosporin, and pertussis toxin, suggesting complex signaling.
- Two hypodense eosinophil populations exhibited differential susceptibility to TNF alpha.
- ROS production was primarily extracellular, localized to cell contact zones.
- TNF alpha binding to 55 kDa and 75 kDa TNF receptors was confirmed.
- TNF alpha did not significantly induce the release of ECP or EPO.
Conclusions:
- TNF alpha is a potent activator of human eosinophils, influencing their morphology and oxidative burst.
- The activation involves specific TNF receptors and complex intracellular signaling pathways.
- TNF alpha's role in allergic inflammation may be mediated through eosinophil activation without significant degranulation.